RTHP-32. PHASE II STUDY OF HYPO-FRACTIONATED ACCELERATED RADIOTHERAPY WITH CONCURRENT AND MAINTENANCE TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA: COMPLIANCE AND EARLY CLINICAL OUTCOME (HyART)

INTRODUCTION: To compare hypo-fractionated (HyRT) with conventional fractionated radiotherapy (CRT) for good prognosis newly diagnosed patients with glioblastoma (GBM). METHODS: HyART, a Phase II trial randomly assigned newly diagnosed GBM patients 1:1 by computer generated randomization chart to Hy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Mallick, Supriya, Haresh, Kunhi parambath, Gupta, Subhash, Sharma, Dayanand, Julka, Pramod, Rath, Goura Kishor
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692008/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.914
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares